Towards the prevention of vein graft failure

International Journal of Cardiology

Volumn 62, Issue SUPPL. 1, 1997, Pages

  Mehta, Dheeraj ^a   Izzat, Mohammed B ^a   Bryan, Alan J ^a   Angelini, Gianni D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Disease and failure; Vein graft

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULATION; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CONFERENCE PAPER; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; COST BENEFIT ANALYSIS; GRAFT FAILURE; GRAFT OCCLUSION; HEALTH CARE COST; HEPARINIZATION; HUMAN; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT; STENT; SURGICAL TECHNIQUE; THROMBOSIS; TREATMENT PLANNING;

EID: 0031438806     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(97)00214-3     Document Type: Conference Paper

References (54)

1. Angelini G.D., Bryan A.J. Extending the use of arterial conduits in myocardial revascularisation. Br Heart J. 68:1992;161-162.
2. Weintraub W.S., Jones E.L., Craver J.M.et al. Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous vein grafts. Am J Cardiol. 73:1994;103-112.
3. Bryan A.J., Angelini G.D. The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr Opinion Cardiol. 9:1994;641-649.
4. Underwood M.J., More R., Weeraseena N., Firmin R.K., de Bono D.P. The effect of surgical preparation and in vitro distension on the intrinsic fibrinolytic activity of human saphenous vein. Eur J Vasc Surg. 7:1993;518-522.
5. Foegh ML, Virmani R, Molecular biology of intimal proliferation, in: Annual of Cardiac Surgery, Yacoub M Pepper J, editors. Current Science: London. 1994:53-65.
6. Davies M.G., Hagen P.-O. Pathobiology of Intimal Hyperplasia. Br J Surg. 81:1994;1254-1269.
7. Schwartz S.M., deBois D., O'Brien E.R.M. The intima. Soil for atherosclerosis and restenosis. Circ Res. 77:1995;445-465.
8. Ip J.H., Fuster V., Badimon L.et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 15:1990;1667-1687.
9. Davies M.G., Hagen P.-O. Pathophysiology of vein graft failure: a review. Eur J Vasc Endovasc Surg. 9:1995;7-18.
10. Angelini G.D., Bryan A.J., Williams H.M.J.et al. Distension promotes platelet and leucocyte adhesion and reduces short term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg. 103:1990;1093-1103.
11. Soyombo A.A., Angelini G.D., Newby A.C. Neointima formation is promoted by surgical preparation and inhibited by cyclic nucleotides in human saphenous vein organ cultures. J Thorac Cardiovasc Surg. 109:1995;2-12.
12. Foegh M.L., Virmani R. Molecular biology of intimal proliferation. Curr Opinion Cardiol. 8:1993;938-950.
13. Druker B.J., Mamon H.J., Roberts T.M. Oncogenes, growth factors, and signal transduction. N Engl J Med. 321:1989;1383-1391.
14. Moggio R.A., Ding J.-Z., Smith C.J.et al. Immediate early gene expression in human saphenous veins harvested during coronary bypass operations. J Thorac Cardiovasc Surg. 110:1995;209-213.
15. Gryglewski R.J., Chlopieki S., Swics J., Niezabitoloski P. Prostacyclin, nitric oxide and atherosclerosis. Ann NY Acad Sci USA. 748:1995;194-207.
16. Eldor A., Falcone D.J., Hajjar D.P., Minick C.R., Weksler B.B. Recovery of prostacyclin production by deendothelialised rabbit aorta: critical role of neointimal smooth muscle. J Clin Invest. 67:1981;735-741.
17. Hannson G.K., Geng Y.-J., Holm J., Hardhammer P., Wennwalm A., Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med. 180:1994;733-738.
18. Jeremy J.Y., Dashwood M.R., Timm M., Izzat M.B., Mehta D., Bryan A.J., Angelini G.D. Nitric Oxide Synthase and Adenylyl and Guanylyl Cyclase Activity in Porcine Interposition Vein Grafts. Ann Thorac Surg. 63:1997;470-476.
19. Newby A.C., George S.J. Proposed roles for growth factors in mediating smooth muscle cell proliferation in vascular pathologies. Cardiovasc Res. 27:1993;1173-1183.
20. Francis S.E., Hunter S., Holt C.M., Gadston P.B., Rogers S., Duff G.W., Newby A.C., Angelini G.D. Release of platelet-derived growth factor activity from arteriovenous bypass grafts. J Thorac Cardiovasc Surg. 108:1994;540-548.
21. Dobrin P.B., Littoy F.N., Endean E.D. Mechanical factors predisposing to intimal hyperplasia and medial thickening in autogenous vein grafts. Surgery. 105:1989;393-400.
22. Hsieh H.-J., Li N.-Q. Frangos JA. Shear stress induced platelet-derived growth factor gene expression in human endothelial cells is mediated by protein kinasc C. J Cell Physiol. 150:1992;552-558.
23. Sterpetti A.V., Cucina A., Fragale A.et al. Shear stress influences the release of platelet-derived growth factor and basic fibroblast growth factor by arterial smooth muscle cells. Eur J Vasc Surg. 8:1994;138-142.
24. Costa K.A., Sumpio B.E., Cerreta J.M. Increased elastin synthesis by cultured bovine aortic smooth muscle cells subjected to repetitive mechanical stretching. FASEB J. 5:1991;1609A.
25. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res. 77:1995;863-868.
26. Newby A.C., Fabnumi R.P., George S.J., Southgate K.M., Banning A.P., Thurston V.J., Williams A. Neointimal fibrosis in vascular pathologies: role of growth factors and metalloproteinases in vascular smooth muscle proliferation. Exp Nephrol. 3:1995;108-113.
27. Southgate K.M., Izzat M.B., Knight D., Angelini G.D. Up regulation of matrix degrading gelatinases in pig saphenous vein grafts. Br Heart J. 73:1995;A143.
28. Southgate K.M., Banning A.P., Groves P.H.et al. Upregulation of basement membrane-degrading metalloproteinases by balloon angioplasty in pigs. Br Heart J. 71(Suppl 5):1994;65.
29. George S.J., Fabnumi R.P., Williams A.et al. Basement membrane metalloproteinaes expression increases during neointimal formation in human saphenous vein organ cultures. Br Heart J. 73(Suppl 5):1995;84.
30. Forough R., Koyama N., Hasenstab D.et al. Overexpression of tissue inhibitor of martix metalloproteinase-1 inhibits vascular smooth muscle cell functions in vitro and in vivo. Circ Res. 79:1996;812-820.
31. Drexel H, Amman FW. Lipids and lipid lowering drugs and graft function, in: Coronary artery graft disease., Luscher T, Turina M, Braunwald E, editors. Springer Verlag: Berlin. 1994:3-15.
32. Boncheck L.E., Olinger G.N., Boncheck L.I., Gunay H., Kissebah A.H., Rodriguez E.R., Ferrans V.J. The relative influence of arterial pressure versus intraoperative distension on lipid accumulation in primate vein bypass grafts. J Thorac Cardiovasc Surg. 90:1985;756-764.
33. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
34. Fremes S.E., Levinton C., Naylor C.D., Chen E., Christakis G.T., Goldman B.S. Optimal antithrombotic therapy following aortocoronary bypass: A meta-analysis. Eur J Cardiothorac Surg. 7:1993;169-180.
35. Collaboration Antiplatelet Trialists'. Collaborative overview of randomised trials of antiplatelet therapy: II. Maintainance of vascular graft or arterial patency by antiplatelet therapy. Br Med J. 308:1994;159-168.
36. Mehta D., Angelini G.D., Bryan A.J. Experimental models of accelerated atherosclerosis syndromes. Int J Cardiol. 56:1996;235-257.
37. Goldman S., Copeland J., Moritz T.et al. Long term graft patency (3 years) after coronary artery surgery. Effects of aspirin: results of VA Cooperative Study. Circulation. 89:1994;1138-1143.
38. Ellis S.G., Roubin G.S., Wilentz J.et al. Effect of 18 to 24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 117:1989;777-782.
39. Edmondson R.A., Cohen A.T., Das S.K.et al. Low molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass grafting. Lancet. 344:1994;914-918.
40. More R.S., Underwood M.J., deBono D.P. Targetting fibrinolytic agents to the vessel wall: a new therapeutic niche? Thromb Haemostas. 71:1994;155-159.
41. Gottlieb SO, Calcium antagonists in patients undergoing coronary artery bypass surgery. in Coronary artery graft disease: Mechanisms and prevention, Luscher T, Turina M, Braunwald E, editors. Springer-Verlag: Berlin. 1994:312-327.
42. Yang Z., Noll G., Luscher T.F. Calcium antagonists differently inhibit proliferation of human coronary smooth muscle cells in response to pulsatile stretch and platelet derived growth factor. Circulation. 88:1993;832-836.
43. Cashin-Hemphill L., Mack W.J., Pogoda J.M.et al. Beneficial effects of cholestipolniacin on coronary atherosclerosis. J Am Med Assoc. 264:1990;3013-3017.
44. Violaris A.G., Newby A.C., Angelini G.D. Effects of external stenting on wall thickening in arteriovenous bypass grafts. Ann Thorac Surg. 55:1993;667-671.
45. Izzat M.B., Mehta D., Bryan A.J.et al. The influence of external stent size on early medial and neointimal thickening in a pig model of saphenous vein bypass grafting. Circulation. 94:1996;1741-1745.
46. Jeremy J.Y., Jackson C.L., Bryan A.J.et al. Eicosanoids, fatty acids and restenosis following balloon angioplasty and vein graft surgery. Prostagl Leukotr Essential Fatty Acids. 54:1996;385-402.
47. Gonschior P., Gerheuser F., Mack B.et al. Local delivery of cytotoxic drugs as an effective approach to prevent tissue hyperplasia in experimental restenosis. Eur Heart J. 15:1994;559.
48. Pickering JG, Bacha PA, Weir I et al. Prevention of smooth muscle cell outgrowth from human atherosclerotic plaque by recombinant cytotoxin specific for the epidermal growth factor receptor. J Clin Invest 1993:724-729.
49. George SJ, Jeremy JY, Angelini GD. Thapsigargin inhibits smooth muscle cell proliferation and intima formation but does not affect metalloproteinase expression in human saphenous vein organ culture. Br J Pharmacol 1997; in press.
50. Foegh M, Virmani R. Molecular biology of intimal proliferation, in: Annual of Cardiac Surgery, Yacoub M, Pepper J, editors. Current Science Ltd: London. 1994:63-65.
51. Bennett M., Anglin S., McEwan J.R., Jagoe R., Newby A.C., Evan G.I. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligonucleotides. J Clin Invest. 93:1994;820-828.
52. Nabel E., Pompili V., Plautz G., Nabel G.J. Gene transfer and vascular disease. Cardiovasc Res. 28:1994;445-455.
53. Nabel E., Yang Z., Liptay S.et al. Recombinant platelet derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest. 91:1993;1822-1829.
54. Baker AH, Mehta D, George SJ, et al. Prevention of vein graft failure: Potential applications for gene therapy. Cardiovasc Res 1997; in press.